Hikma Pharmaceuticals Plc – Strategy, SWOT and Corporate Finance Report

Hikma Pharmaceuticals Plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360Ëš view of the company.

Hikma Pharmaceuticals Plc (Hikma) develops, manufactures and markets branded and non-branded generics and in-licensed products. The company specializes in the therapeutic areas of cardiovascular, diabetes, central nervous system (CNS), cancer, dermatology, genitourinary system, hormones and respiratory system, among others. It offers generics in various dosage forms including tablets, capsules, solutions and suspensions. Hikma Pharmaceuticals sells its products through sales and marketing teams and representatives to leading wholesalers, pharmacy chains, governments and hospital purchasing organizations. The company markets its products in the UK, the Middle East and North Africa (MENA) and Europe and Rest of the World (ROW). Hikma Pharmaceuticals is headquartered in London, the UK.

Scope

Detailed information on Hikma Pharmaceuticals Plc required for business and competitor intelligence needs

A study of the major internal and external factors affecting Hikma Pharmaceuticals Plc in the form of a SWOT analysis

An in-depth view of the business model of Hikma Pharmaceuticals Plc including a breakdown and examination of key business segments

News about Hikma Pharmaceuticals Plc, such as business expansion, restructuring, and contract wins

Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

Gain understanding of Hikma Pharmaceuticals Plc and the factors that influence its strategies.

Track strategic initiatives of the company and latest corporate news and actions.

Assess Hikma Pharmaceuticals Plc as a prospective partner, vendor or supplier.

Support sales activities by understanding your customers' businesses better.

Stay up to date on Hikma Pharmaceuticals Plcs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Theravance Biopharma Inc

Teva Pharmaceutical Industries Ltd

Sandoz International GmbH

Novartis Pharmaceuticals UK Ltd

Napp Pharmaceuticals Ltd

Lannett Company Inc

Table of Contents

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Hikma Pharmaceuticals Plc - Key Facts

Hikma Pharmaceuticals Plc - Key Employees

Hikma Pharmaceuticals Plc - Key Employee Biographies

Hikma Pharmaceuticals Plc - Major Products and Services

Hikma Pharmaceuticals Plc - History

Hikma Pharmaceuticals Plc - Company Statement

Hikma Pharmaceuticals Plc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 Company Analysis

Company Overview

Hikma Pharmaceuticals Plc - Business Description

Business Segment: Branded

Overview

Performance

Business Segment: Generics

Overview

Performance

Business Segment: Injectables

Overview

Performance

Business Segment: Others

Performance

Geographical Segment: Europe and Rest of the World

Performance

Geographical Segment: Middle East and North Africa

Performance

Geographical Segment: The UK

Performance

Geographical Segment: The US

Performance

R&D Overview

Hikma Pharmaceuticals Plc - Corporate Strategy

Hikma Pharmaceuticals Plc - SWOT Analysis

SWOT Analysis - Overview

Hikma Pharmaceuticals Plc - Strengths

Hikma Pharmaceuticals Plc - Weaknesses

Hikma Pharmaceuticals Plc - Opportunities

Hikma Pharmaceuticals Plc - Threats

Hikma Pharmaceuticals Plc - Key Competitors

Section 3 Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 Company’s Lifesciences Financial Deals and Alliances

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Hikma Pharmaceuticals Plc, Recent Deals Summary

Section 5 Company’s Recent Developments

Mar 13, 2019: Hikma delivers strong 2018 results and makes good strategic progress to position for future growth

Mar 12, 2019: Hikma board appoints Cynthia Schwalm as director

Nov 30, 2018: Hikma demonstrates support for US pharmacists and patient safety

Nov 09, 2018: Vectura and Hikma to jointly develop generic versions of GSK’s Ellipta

Nov 08, 2018: Hikma updates on current trading and raises 2018 guidance

Oct 04, 2018: Hikma Pharmaceuticals names Sagar Patel as European Commercial Head for Injectables

Oct 04, 2018: Hikma Appoints Global Head of Intellectual Property and US General Counsel

Aug 16, 2018: Hikma Pharmaceuticals appoints Kristy Ronco executive vice president, sales and marketing, generics

Aug 15, 2018: Hikma Pharmaceuticals: Half-year report

Section 6 Appendix

Methodology

Ratio Definitions

About GlobalData

Contact Us

Disclaimer

List of Tables

List of Tables

Hikma Pharmaceuticals Plc, Key Facts

Hikma Pharmaceuticals Plc, Key Employees

Hikma Pharmaceuticals Plc, Key Employee Biographies

Hikma Pharmaceuticals Plc, Major Products and Services

Hikma Pharmaceuticals Plc, History

Hikma Pharmaceuticals Plc, Subsidiaries

Hikma Pharmaceuticals Plc, Joint Venture

Hikma Pharmaceuticals Plc, Key Competitors

Hikma Pharmaceuticals Plc, Ratios based on current share price

Hikma Pharmaceuticals Plc, Annual Ratios

Hikma Pharmaceuticals Plc, Annual Ratios (Cont…1)

Hikma Pharmaceuticals Plc, Annual Ratios (Cont…2)

Hikma Pharmaceuticals Plc, Interim Ratios

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Type, 2013 to YTD 2019

Hikma Pharmaceuticals Plc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Hikma Pharmaceuticals Plc, Performance Chart (2014 – 2018)

Hikma Pharmaceuticals Plc, Ratio Charts

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals By Year, 2013 to YTD 2019

Hikma Pharmaceuticals Plc, Pharmaceuticals & Healthcare, Deals by Type, 2013 to YTD 2019

    Pricing

Discounts available for multiple report purchases.

reportstore@marketline.com
+44 (0) 161 359 5817

Saved reports